SUMMARY The feasibility of imaging the inflammatory response to acute transmural myocardial infarction in man using biologically active indium-111 ("'ln)-labeled autologous leukocytes was assessed in 36 patients. Indium-111 leukocytes (approximately 500 ,tCi) were injected i.v. 18-112 hours after the onset of chest pain. Cardiac imaging was performed 24 hours later with a mobile gamma camera. Twenty-one patients had positive images and 15 had negative images. The percent of positive images increased as the interval between infarction and "'In-leukocyte injection shortened; all patients injected within 24 hours of infarction had positive images. Patients with positive images were injected with "'In leukocytes earlier after infarction (mean ± SEM, 43 ± 4 vs 63 ± 7 hours; p < 0.05) and were younger (53 ± 2 vs 65 ± 3 years; p < 0.05) than those with negative images. Several other parameters that could possibly have affected the imaging results were examined and were not significantly different in patients with positive and negative images. These included peak serum creatine kinase, location of infarction, incidence of pericarditis, use of antiinflammatory drugs (aspirin and indomethacin) or membrane-active antiarrhythmic drugs (lidocaine and procainamide), peripheral leukocyte count and cell labeling efficiency. The function of the labeled cells was similar in patients with positive and negative images. Six patients with acute infarction serving as controls and given free "`In oxine and six patients with stable coronary artery disease given "`In leukocytes all had negative cardiac images.
INFILTRATION of leukocytes into the region of acute myocardial infarction in man is present histologically within 24 hours and is maximal 4-5 days after infarction.' Weiss et al. first imaged the inflammatory response to acute myocardial infarction in dogs using indium-i1 1 ("'In)-labeled leukocytes. ' Thakur et al. recently extended these observations and demonstrated that discrete uptake of radioactivity could be imaged in animals [1] [2] [3] [4] days after infarction, but not after 5 days. Furthermore, uptake was maximal in the lowest flow zones and occurred 24 hours after infarction in the epicardium and 72 hours after infarction in the endocardium. 3 The physical properties of "'In, with a half-life of 2.8 days and gamma photopeaks of 173 and 247 keV, make it suitable for imaging with conventional gamma cameras. Indium-11 oxine is lipid soluble and is incorporated intracellularly when added to separated leukocytes. 4 The labeled cells maintain their viability, functional capacity and morphologic integrity.' The half-life of circulating labeled leukocytes is approximately 7.5 hours6 and blood pool radioactivity clears by 24 hours, allowing cardiac imaging at that time. 7 This study was undertaken to evaluate the feasibility of imaging the inflammatory response to acute myocardial infarction in man using autologous "'In leukocytes and not to define its accuracy, sensitivity or specificity as a new diagnostic test. In addition, we assessed factors that might affect the cellular uptake.
Methods Preparation of "'In Leukocytes
Autologous leukocytes were isolated and labeled with "'In using minor modifications of the technique of Thakur et al. 3 Briefly, using sterile techniques, 30 ml of venous blood were drawn into a disposable plastic syringe containing 200 IU preservative-free heparin (Abbott Laboratories). The blood settled by gravity for 1 hour at room temperature in a laminar flow hood. The plasma supernatant containing leukocytes and platelets was transferred into one or two 15-ml round bottom polyethylene test tubes (Falcon) and spun at 450 g for 5 minutes in a lead-shielded centrifuge at room temperature. The platelet-rich plasma was removed with a Pasteur pipette and stored in a 15-ml polyethylene test tube. The leukocyte pellet was INFLAMMATORY RESPONSE TO AMI BY INDIUM/Davies et al.
temperature. Commercial "'In oxine (1 mCi "'In and 50 ,ug oxine in 50 ,ul ethanol, from Diagnostic Isotopes) diluted fourfold with saline, was used in 31 patients. Indium-ill oxine, prepared by chelation of "'In chloride to 8-hydroxyquinilone in the laboratory, was used for five patients.8 After 15 minutes of incubation, 5 ml of plasma were added and the cell suspension was centrifuged at 450 g for 5 minutes. The supernatant containing unincorporated isotope was removed. Radioactivity in the leukocyte button and in the supernatant was measured in a dose calibrator (Capintec). The percent cell labeling efficiency was determined (activity in leukocyte button/activity in original suspension X 100). The leukocyte button was resuspended in 10 ml of the original plasma and the appropriate volume was drawn up in a 10-ml plastic syringe to give 500-600 ,uCi labeled leukocytes. This was reinjected intravenously into the patient as soon as possible. The remaining labeled leukocyte suspension was saved for tests of erythrocyte contamination (41 studies); yeast phagocytic ability (15 studies); and ability to adhere to nylon wool (13 studies) in randomly selected patients.
Assessment of "'In Leukocyte Function
Percentage erythrocyte contamination of the labeled leukocyte preparation was performed by counting 100 successive cells on an air-dried Wright's stained smear of the cell suspension using oilimmersion microscopy. Morphology of the labeled leukocytes also was examined.
Leukocyte phagocytic ability was assessed after incubation of two drops of cell suspension with one drop of nitroblue tetrazolium (NBT) and one drop of yeast suspension (107 organisms/ml) for 20 Two control groups of patients also were studied. One group consisted of six patients with acute myocardial infarction, ages 30-79 years, who were given 500 gCi of free "'In oxine 15-62 hours after infarction. These patients were clinically indistinguishable from the study group. The other control group consisted of six patients, ages 60-76 years, with stable coronary artery disease given "'In leukoeytes. The latter group was admitted electively for cardiac catheterization. None had sustained acute myocardial infarction within 2 months; all had angiographically documented coronary artery disease.
Cardiac Imaging
Bedside cardiac imaging was performed 24 hours after the injection of "'In leukocytes or free "'In oxine. This interval was chosen on the basis of data from experimental animals demonstrating clearance of most of the circulating blood pool radioactivity by 24 hours, permitting detection of myocardial uptake distinct from blood pool background.3' 7 Persistent blood pool radioactivity was seen 24 hours after "llInleukocyte injection in three of 36 study patients. Imaging in these patients was repeated again 24 hours later (48 hours after injection). Circulating blood pool radioactivity took longer to clear after the injection of free "'In oxine because of binding to plasma transfusion'4 and imaging was repeated 48 hours after injection in four of these six control patients. Cardiac imaging was performed with a mobile scintillation camera, interfaced with a small dedicated computer.
The camera was equipped with a custom-made, highresolution, medium-energy, parallel-hole collimator.
Simultaneous dual-peak imaging was performed using 20% windows around both photo peaks (173 and 247 keV) of "'In. Both unprocessed analog and computer digital images were collected on Polaroid film. Onehundred-thousand-count images were collected in the anterior and 450 left anterior oblique positions and occasionally in the left lateral position.
An image was defined as positive for myocardial uptake of "'.In-labeled leukocytes if there was activity in the region of the heart distinctly above background, in a pattern not resembling blood pool activity. Focal uptake was defined as a discrete zone of radioactivity distinctly greater than background, localized to one region of the left ventricle. Nonfocal uptake was defined as visualized activity in the region of the heart distinctly above background activity and different in appearance from blood pool activity, which could not be localized to one region of the left ventricle. Localization of "'In leukocyte in the heart was based upon the position of the uptake relative to the position of splenic, hepatic and sternal uptake. The images were interpreted by four observers and a consensus was reached.
Statistical Analysis
Data are expressed as mean i SFM. Statistical difference between the means of two groups were tested using a t test. Differences between ratios of patients within each of two groups were analyzed by chi-square with Yates correction for small group size. A p value < 0.05 was considered significant.
Results

Cardiac Imaging
Twenty-four hours after the injection of "'In leukocytes, there was intense splenic uptake, moderately intense hepatic uptake, modest sternal and vertebral uptake and lesser rib activity. None Cardiac images after the injection of "'In leukocytes revealed more skeletal uptake than after free "'In-oxine administration. The reason for skeletal uptake after "'In-leukocyte injection is not known precisely,'8 but could be due to bone marrow uptake of polymorphonuclear leukocytes. Lymphocytes, which are known to recirculate between the blood, lymphoid tissue and bone marrow, are not separated from the polymorphonuclear leukocytes by our centrifugation technique and are labeled with "'In. This also could be responsible for some of the bone activity. '4 Before "'In leukocytes can be used to assess infarction on a broader investigational scale, further insights into leukocyte uptake in infarcted tissue must be obtained. The inflammatory response may influence the degree of tissue injury that occurs as a result of an ischemic insult. Proteolytic enzymes released by granulocytes may increase the extent of ischemic injury. 19, 20 In experimental models, reducing the degree of inflammation with pharmacologic agents working by different mechanisms can reduce apparent infarct size and the extent of ischemic necrosis. [20] [21] [22] [23] [24] [25] Imaging with "'In leukocytes clearly is not meant to replace already available clinical radionuclide means of detecting acute infarction but should be viewed as an investigational method which in the future may be suitable for studying the pathophysiology of inflammation in acute infarction. However, the insensitivity of the technique and its frequent poor localization make it difficult to use in patients. Technically, "'In-leukocyte uptake in some inferior infarctions could have been obscured due to the proximity of intense liver and spleen activity to the inferior wall of the heart. Based on the relatively low proportion of patients with focally positive images in this study, it is unlikely that this imaging technique can be applied to the study of groups of patients receiving drug interventions during the early hours of acute infarction. However, although this initial study has demonstrated a relative insensitivity of the technique, these observations may be modified in the future when additional studies specifically investigate the variety of biologic factors generally affecting leukocyte function in the setting of acute myocardial necrosis. Furthermore, additional work is necessary in defining means of augmenting radiopharmaceutical delivery to the infarct zone without either affecting cellular function or resulting in an excessive radiation burden to the patient.
